Ocular Therapeutix, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Bedford, MA
OCUL chart
What traders are saying about $OCUL
Latest postsOcular Therapeutix, Inc news
- Piper Sandler Remains a Buy on BridgeBio Oncology Therapeutics (BBOT)
The Globe and Mail ·
- Weekly Recap: AXPAXLI 505(b)(2) NDA filing and $600M cash runway
TradingView ·
- Understanding Momentum Shifts in (OCUL)
Stock Traders Daily ·
- Ocular Therapeutix rated Buy with $7.90 target after strong Phase 3 results and expected 2027 launch.
Pluang ·
- Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity
Seeking Alpha ·
- Ocular Therapeutix on track to file AXPAXLI NDA in Q4 after positive FDA pre-NDA meeting
Pluang ·
- Ocular Therapeutix, Inc. Estimates – NASDAQ:OCUL
TradingView ·
- New Planet Labs Price Target After SpaceX Satellite Launch
TheStreet Pro ·
- Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Palvella Therapeutics (PVLA)
The Globe and Mail ·
- Ocular Therapeutix management to meet with Piper Sandler
TipRanks ·
- Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win
marketbeat.com ·
- Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
Yahoo Finance ·
Ocular Therapeutix, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $52.0M | $63.7M | $58.4M | $51.5M |
| Net income | -$265.9M | -$193.5M | -$80.7M | -$71.0M |
| Diluted EPS | $-1.42 | $-1.22 | $-1.02 | $-0.97 |
| Total assets (year end) | $808.1M | $457.9M | $252.1M | $149.3M |
| Cash and equivalents (year end) | $737.1M | $392.1M | $195.8M | $102.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ocular Therapeutix, Inc
- Ticker
- OCUL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bedford, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1393434
- Former names
- I-THERAPEUTIX INC
Frequently asked questions
What exchange is Ocular Therapeutix, Inc listed on?
Ocular Therapeutix, Inc trades on the Nasdaq under the ticker symbol OCUL.
What industry is Ocular Therapeutix, Inc in?
Ocular Therapeutix, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ocular Therapeutix, Inc headquartered?
Ocular Therapeutix, Inc's business address on file with the SEC is in Bedford, MA.
When does Ocular Therapeutix, Inc's fiscal year end?
Ocular Therapeutix, Inc's fiscal year ends on December 31.
How much revenue did Ocular Therapeutix, Inc report?
Ocular Therapeutix, Inc reported $52.0M in revenue for calendar year 2025, according to its SEC filings.